ResMed Aktie
216,30
EUR
-1,30
EUR
-0,60
%
255,94
USD
-1,10
USD
-0,43
%
Werbung
ResMed Aktie Analyse
| 25.09.17 | ResMed Underweight | Barclays Capital | |
| 07.04.16 | ResMed Underweight | Barclays Capital | |
| 27.01.15 | ResMed Under Perform | Northland Capital |
Werbung
Werbung